|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Novacea Inc: Premium Company Profile
Novacea is a development stage biopharmaceutical company engaged in in-licensing, developing and commercializing of novel therapies for the treatment of diseases in the therapeutic area of oncology. The company’s lead candidate, Ascenter, is a Ph
C.R. Bard Inc: Premium Company Profile
C.R. Bard (Bard), which celebrated its centenary in 2007, is one of the leading global developer, manufacturer and marketer of medical technologies in the fields of vascular, urology, oncology and surgical specialty products. The company has pioneered
Incyte Corporation: Premium Company Profile
Incyte is a development stage company involved in drug discovery and development activities with major focus on developing small molecule drugs to treat various diseases. The company has proprietary product pipeline in various stages of development for
Becton, Dickinson and Co: Premium Company Profile
Becton, Dickinson and Company (BD), a medical technology company, improves drug therapy, enhances the diagnosis of infectious diseases and advances drug discovery. It manufactures and sells a broad range of medical supplies, devices, laboratory equipme
Antisoma plc: Premium Company Profile
Antisoma is a development stage biotechnology company focused on the development of novel anticancer drugs. The Company has built a diversified product pipeline based on in-licensing and acquisitions that target a variety of tumors by different mechani
Varian Medical Systems Inc: Premium Company Profile
Varian Medical Systems (Varian) is one of the leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company is also a supplier of tub
Cytori Therapeutics Inc: Premium Company Profile
Cytori Therapeutics (previously MacroPore Biosurgery), based in San Diego, California, is one of the leading companies in the development and commercialization of regenerative medicine products.
Transition Therapeutics Inc: Premium Company Profile
Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. The company’s patented drug discovery technologies have helped the company in expanding its pipeline portfolio.
Lexicon Pharmaceuticals Inc: Premium Company Profile
Lexicon Pharmaceuticals is a biopharmaceutical company focused on clinical development in the areas of irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. The company uses its proprietary gene knockout technology
<< Start < Prev 1 2 3 4 5 6 |